Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update
2021年3月10日 - 6:30AM
Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical
company advancing new treatments for patients suffering from
serious diseases but underserved by today’s therapies, today
announced that it will host a conference call and webcast on
Thursday, March 25, 2021 at 4:30 p.m. ET to discuss a corporate
update and results for the fourth quarter and full year 2020.
Conference Call & Webcast
Details |
Date: |
Thursday,
March 25, 2021 |
Time: |
4:30 pm Eastern Time |
Domestic: |
877-407-0789 |
International: |
201-689-8562 |
Conference ID: |
13717079 |
Webcast: |
https://investors.viridiantherapeutics.com/events/default.aspx |
A live webcast of the conference call can be accessed in the
Investors section of Viridian Therapeutics website at
https://investors.viridiantherapeutics.com
About Viridian Therapeutics
Viridian Therapeutics is a biotechnology company advancing new
treatments for patients suffering from serious diseases but
underserved by today’s therapies. Viridian’s most advanced program,
VRDN-001, is an anti-IGF-1R monoclonal antibody in development for
thyroid eye disease (TED), a debilitating auto-immune disease that
causes inflammation and fibrosis within the orbit of the eye which
can cause double vision, pain, and potential blindness. Patients
with severe disease often require multiple remedial surgeries to
the orbit, eye muscles and eyelids Viridian is headquartered in
Boulder, Colorado, with additional operations in Waltham,
Massachusetts. Learn more about Viridian and our programs at
www.viridiantherapeutics.com.
Follow us on Twitter @ViridianThera and on LinkedIn.
Contacts:
InvestorsDan FerryLifeSci
Advisors617-430-7576IR@viridiantherapeutics.com
MediaDarby PearsonVerge Scientific
Communications703-587-0831PR@viridiantherapeutics.com
Viridian Therapeutics (NASDAQ:VRDN)
過去 株価チャート
から 6 2024 まで 7 2024
Viridian Therapeutics (NASDAQ:VRDN)
過去 株価チャート
から 7 2023 まで 7 2024